missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human AIFM3 Synthetic Peptide
Synthetic Peptide
Marque: Invitrogen™ PEP0623
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
AIFM3 Synthetic Peptide, PEP-0623, from Invitrogen.
Apoptosis, also known as programmed cell death, plays major roles in development and normal tissue turnover in addition to tumor formation. Recently a protein similar to the apoptosis-inducing factor (AIF) was cloned and designated AIFL (also known as AIFM3). AIFM3 is expressed ubiquitously and is predominantly localized to the inner membranes of mitochondria. Unlike AIF, AIFM3 does not translocate to the nucleus upon induction of apoptosis. However, overexpression of AIFM3, like AIF, induced cytochrome c release from the mitochondria, cleavage of caspase 3, and ultimately apoptosis, indicating AIFM3 induces apoptosis through caspase activation. Multiple isoforms of AIFM3 are known to exist.
Spécification
150209 | |
purified | |
Human AIFM3 | |
-20°C | |
Liquid | |
Blocking Assay, Control | |
No | |
Peptide | |
RUO - research use only |
Human | |
Q96NN9 | |
200 μg/mL | |
Synthetic Peptide | |
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 | |
AIFM3 | |
0.02% sodium azide | |
50 μg | |
PBS |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Invitrogen™ Human AIFM3 Synthetic Peptide > 50 μg
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu